XCE tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The molecular structure of XCE tirzepatide (C225H348N48O68) enables balanced activation of both GIP and GLP-1 receptors, with particular affinity for GIP receptors. This unique mechanism provides enhanced metabolic effects in research settings.
Our XCE tirzepatide is produced under strict quality control measures to ensure 99%+ purity as verified by HPLC analysis. The white powder formulation maintains excellent stability when stored properly.
For research purposes only. Not for human consumption. This product is intended solely for laboratory research by qualified professionals.